India’s healthcare system has long been designed around treating illness, not preventing it. But as lifestyle diseases rise and life expectancy increases, a new category of care is beginning to take shape — one focused on longevity, health optimisation, and staying well for longer. Biopeak, India’s first longevity and health optimisation brand, is building precisely that system, and it has now raised $2.7 million in a follow-on funding round led by repeat investor Nikhil Kamath through NKSquared, the investment arm of Zerodha.
The fresh capital marks a strong vote of confidence in Biopeak’s approach to building structured, clinically grounded preventive care models designed specifically for Indian health needs.
Credits: The Economic Times
Repeat Investment Signals Growing Confidence in Biopeak’s Model
The follow-on round underscores continued conviction in Biopeak’s long-term vision — strengthening healthspan at a population level through early detection, longitudinal tracking, and specialist-led interventions. While India has made significant strides in acute and episodic care, organised systems that focus on prevention, risk identification, and long-term health optimisation remain limited.
Biopeak is working to close this gap by creating a multidisciplinary model that connects diagnostics, specialists, and ongoing follow-up into a single, cohesive care pathway. This structure allows individuals to move beyond reactive healthcare and into a continuous system of health monitoring and optimisation, tailored to Indian disease patterns and lifestyle risks.
Building India-First Longevity Care, Backed by Clinical Rigor
At the core of Biopeak’s offering is a clinically anchored, India-first care model. Its programs are led by multidisciplinary specialist teams and supported by advanced diagnostics and proprietary AI-driven insights. This combination allows for earlier identification of health risks, more targeted clinical interventions, and sustained follow-up over time — something that has historically been fragmented in the Indian healthcare system.
Rather than focusing on one-off wellness checks or generic fitness programs, Biopeak’s approach is designed to support recovery, regeneration, and long-term health resilience. By grounding longevity care in clinical science and data, the company is creating a system that bridges the gap between traditional healthcare and modern preventive medicine.
Capital to Fuel Expansion, Research, and AI Capabilities
The newly raised funds will be deployed to expand Biopeak’s clinical footprint and deepen its capabilities across diagnostics, research, and technology. A key part of this expansion includes the launch of a new flagship centre in Bengaluru, which will serve as a hub for advanced longevity programs, clinical research, and innovation.
Biopeak also plans to invest further in its proprietary AI platform, which integrates diagnostic data, health history, and longitudinal tracking to support more consistent clinical decision-making. In parallel, the company will expand its clinical, research, product, and operations teams to support scale while maintaining strong clinical governance.
Rising Demand for Structured Preventive Care
Over the past year, Biopeak has reported steady growth in its clinical programs and patient engagement, reflecting a broader shift in how Indians approach health. With growing awareness around lifestyle diseases, metabolic health, and ageing-related risks, more consumers are actively seeking structured, specialist-led preventive care rather than episodic consultations.
Biopeak’s model — which combines diagnostics, clinical expertise, and long-term engagement — is resonating with this emerging demand, particularly among individuals looking for data-backed, personalised health plans that evolve over time.
Credits: Medial
Strengthening Global Partnerships and Clinical Governance
As Biopeak scales, it is also strengthening its network of global advisors and institutional partners to advance protocol development and clinical governance. These collaborations are expected to help standardise longevity care practices while ensuring that programs remain evidence-based, ethical, and clinically sound.
Commenting on the fundraise, Rishi Pardal, Co-founder and CEO of Biopeak, said the shift in mindset around health is becoming increasingly clear. “In India, we’re seeing a real shift in how people think about health — not just when something goes wrong, but how they stay well over time. What’s been missing is a clinical system that connects diagnostics, specialists, and follow-up into one long-term view of health,” he said.
With fresh capital, repeat investor backing, and rising consumer acceptance, Biopeak is now positioned to accelerate its mission — building a preventive healthcare system that helps Indians live not just longer, but better.
